CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly licensed Geenius test is an immunochromatographic assay designed to confirm and differentiate individual antibodies to Human Immunodeficiency Virus Types 1 and 2. The assay will be replacing the HIV-1 Western blot and HIV-2 EIA assays which are performed on samples with a reactive result on a licensed HIV 1/2 screening test.
Read all about it on the Communication page by clicking this link: Communications
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
The new online Learning Center with new content can still be found under the “Training” folder on ...